Skip to main content

and
  1. Article

    Open Access

    Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

    After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-yea...

    HP Knaebel, A Märten, J Schmidt, K Hoffmann, C Seiler, K Lindel in BMC Cancer (2005)

  2. Article

    Open Access

    Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease

    STI571 is a selective tyrosine kinase inhibitor with proven therapeutic potential in malignancies expressing c-kit. A strong c-kit and stem cell factor expression was detected in the Hodgkin and Reed Sternberg ce...

    D Re, C Wickenhauser, T Ahmadi, E Buchdunger, M Kochanek in British Journal of Cancer (2002)

  3. Article

    Open Access

    Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236

    Hodgkin-Reed Sternberg cells are derived from germinal centre B-cells in most cases. Somatic mutations affecting their rearranged immunoglobulin genes were detected, rendering potential functional rearrangemen...

    A Staratschek-Jox, R Kurt Thomas, T Zander, N Massoudi in British Journal of Cancer (2001)

  4. Article

    Open Access

    An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA’) is a potent immunotoxin against a Hodgkin-derived cell line

    The human CD30 receptor is highly overexpressed on the surface of Hodgkin Reed-Sternberg cells and has been shown to be an excellent target for selective immunotherapy using monoclonal antibody-based agents su...

    A Klimka, S Barth, B Matthey, R C Roovers, H Lemke, H Hansen in British Journal of Cancer (1999)

  5. No Access

    Article

    Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitope

    Mucus glycoproteins of human amniotic fluid were used to generate a monoclonal antibody (MAb) FW6, which stained the intestine of a 24 week stage fetus. In adults, 76% of colonic adenocarcinomas (13/17) showed...

    M Schwonzen, R Schmits, SE Baldus, M Vierbuchen, F-G Hanisch in British Journal of Cancer (1992)